0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug-Coated Balloon for Peripheral Artery Diseases Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-37G13112
Home | Market Reports | Health| Medical Devices & Equipment
Global Drug Coated Balloon for Peripheral Artery Diseases Market Research Report 2023
BUY CHAPTERS

Global Drug-Coated Balloon for Peripheral Artery Diseases Market Research Report 2025

Code: QYRE-Auto-37G13112
Report
March 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug-Coated Balloon for Peripheral Artery Diseases Market Size

The global market for Drug-Coated Balloon for Peripheral Artery Diseases was valued at US$ 679 million in the year 2024 and is projected to reach a revised size of US$ 1783 million by 2031, growing at a CAGR of 15.0% during the forecast period.

Drug-Coated Balloon for Peripheral Artery Diseases Market

Drug-Coated Balloon for Peripheral Artery Diseases Market

Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug-Coated Balloon for Peripheral Artery Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Coated Balloon for Peripheral Artery Diseases.
The Drug-Coated Balloon for Peripheral Artery Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug-Coated Balloon for Peripheral Artery Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Coated Balloon for Peripheral Artery Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug-Coated Balloon for Peripheral Artery Diseases Market Report

Report Metric Details
Report Name Drug-Coated Balloon for Peripheral Artery Diseases Market
Accounted market size in year US$ 679 million
Forecasted market size in 2031 US$ 1783 million
CAGR 15.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Paclitaxel Coated
  • Other Coated
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Boston Scientific, BD, Philips, Aachen Resonance
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug-Coated Balloon for Peripheral Artery Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug-Coated Balloon for Peripheral Artery Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Drug-Coated Balloon for Peripheral Artery Diseases Market growing?

Ans: The Drug-Coated Balloon for Peripheral Artery Diseases Market witnessing a CAGR of 15.0% during the forecast period 2025-2031.

What is the Drug-Coated Balloon for Peripheral Artery Diseases Market size in 2031?

Ans: The Drug-Coated Balloon for Peripheral Artery Diseases Market size in 2031 will be US$ 1783 million.

Who are the main players in the Drug-Coated Balloon for Peripheral Artery Diseases Market report?

Ans: The main players in the Drug-Coated Balloon for Peripheral Artery Diseases Market are Medtronic, Boston Scientific, BD, Philips, Aachen Resonance

What are the Application segmentation covered in the Drug-Coated Balloon for Peripheral Artery Diseases Market report?

Ans: The Applications covered in the Drug-Coated Balloon for Peripheral Artery Diseases Market report are Hospitals, ASCs, Catheterization Laboratory

What are the Type segmentation covered in the Drug-Coated Balloon for Peripheral Artery Diseases Market report?

Ans: The Types covered in the Drug-Coated Balloon for Peripheral Artery Diseases Market report are Paclitaxel Coated, Other Coated

Recommended Reports

Drug Coated Devices

Peripheral Vascular Intervention

Balloon Catheter Technologies

1 Drug-Coated Balloon for Peripheral Artery Diseases Market Overview
1.1 Product Definition
1.2 Drug-Coated Balloon for Peripheral Artery Diseases by Type
1.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Value Comparison by Type (2024 VS 2031)
1.2.2 Paclitaxel Coated
1.2.3 Other Coated
1.3 Drug-Coated Balloon for Peripheral Artery Diseases by Application
1.3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Estimates and Forecasts
1.4.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue 2020-2031
1.4.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales 2020-2031
1.4.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug-Coated Balloon for Peripheral Artery Diseases Market Competition by Manufacturers
2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug-Coated Balloon for Peripheral Artery Diseases, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases, Product Type & Application
2.7 Global Key Manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases, Date of Enter into This Industry
2.8 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Competitive Situation and Trends
2.8.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug-Coated Balloon for Peripheral Artery Diseases Players Market Share by Revenue
2.8.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Scenario by Region
3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region: 2020-2031
3.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region: 2020-2025
3.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region: 2026-2031
3.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region: 2020-2031
3.3.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region: 2020-2025
3.3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region: 2026-2031
3.4 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Facts & Figures by Country
3.4.1 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2031)
3.4.3 North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Facts & Figures by Country
3.5.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2031)
3.5.3 Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Facts & Figures by Region
3.6.1 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Market Facts & Figures by Country
3.7.1 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2031)
3.7.3 Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2020-2031)
4.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2020-2025)
4.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (2026-2031)
4.1.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2020-2031)
4.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2020-2031)
4.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2020-2025)
4.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Type (2026-2031)
4.2.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2020-2031)
4.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2020-2031)
5.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2020-2025)
5.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2026-2031)
5.1.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2020-2031)
5.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2020-2031)
5.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2020-2025)
5.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Application (2026-2031)
5.2.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application (2020-2031)
5.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Philips
6.4.1 Philips Company Information
6.4.2 Philips Description and Business Overview
6.4.3 Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolio
6.4.5 Philips Recent Developments/Updates
6.5 Aachen Resonance
6.5.1 Aachen Resonance Company Information
6.5.2 Aachen Resonance Description and Business Overview
6.5.3 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Portfolio
6.5.5 Aachen Resonance Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-Coated Balloon for Peripheral Artery Diseases Industry Chain Analysis
7.2 Drug-Coated Balloon for Peripheral Artery Diseases Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-Coated Balloon for Peripheral Artery Diseases Production Mode & Process Analysis
7.4 Drug-Coated Balloon for Peripheral Artery Diseases Sales and Marketing
7.4.1 Drug-Coated Balloon for Peripheral Artery Diseases Sales Channels
7.4.2 Drug-Coated Balloon for Peripheral Artery Diseases Distributors
7.5 Drug-Coated Balloon for Peripheral Artery Diseases Customer Analysis
8 Drug-Coated Balloon for Peripheral Artery Diseases Market Dynamics
8.1 Drug-Coated Balloon for Peripheral Artery Diseases Industry Trends
8.2 Drug-Coated Balloon for Peripheral Artery Diseases Market Drivers
8.3 Drug-Coated Balloon for Peripheral Artery Diseases Market Challenges
8.4 Drug-Coated Balloon for Peripheral Artery Diseases Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug-Coated Balloon for Peripheral Artery Diseases Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug-Coated Balloon for Peripheral Artery Diseases, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases, Product Type & Application
 Table 12. Global Key Manufacturers of Drug-Coated Balloon for Peripheral Artery Diseases, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug-Coated Balloon for Peripheral Artery Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Coated Balloon for Peripheral Artery Diseases as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region (2020-2025)
 Table 19. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region (2026-2031)
 Table 21. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2020-2025)
 Table 53. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2026-2031)
 Table 54. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug-Coated Balloon for Peripheral Artery Diseases Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drug-Coated Balloon for Peripheral Artery Diseases Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2020-2025)
 Table 63. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2026-2031)
 Table 64. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug-Coated Balloon for Peripheral Artery Diseases Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drug-Coated Balloon for Peripheral Artery Diseases Price (US$/Unit) by Application (2026-2031)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BD Drug-Coated Balloon for Peripheral Artery Diseases Product
 Table 84. BD Recent Developments/Updates
 Table 85. Philips Company Information
 Table 86. Philips Description and Business Overview
 Table 87. Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Philips Drug-Coated Balloon for Peripheral Artery Diseases Product
 Table 89. Philips Recent Developments/Updates
 Table 90. Aachen Resonance Company Information
 Table 91. Aachen Resonance Description and Business Overview
 Table 92. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product
 Table 94. Aachen Resonance Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Drug-Coated Balloon for Peripheral Artery Diseases Distributors List
 Table 98. Drug-Coated Balloon for Peripheral Artery Diseases Customers List
 Table 99. Drug-Coated Balloon for Peripheral Artery Diseases Market Trends
 Table 100. Drug-Coated Balloon for Peripheral Artery Diseases Market Drivers
 Table 101. Drug-Coated Balloon for Peripheral Artery Diseases Market Challenges
 Table 102. Drug-Coated Balloon for Peripheral Artery Diseases Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug-Coated Balloon for Peripheral Artery Diseases
 Figure 2. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Type: 2024 & 2031
 Figure 4. Paclitaxel Coated Product Picture
 Figure 5. Other Coated Product Picture
 Figure 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. ASCs
 Figure 10. Catheterization Laboratory
 Figure 11. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (2020-2031) & (K Units)
 Figure 14. Global Drug-Coated Balloon for Peripheral Artery Diseases Average Price (US$/Unit) & (2020-2031)
 Figure 15. Drug-Coated Balloon for Peripheral Artery Diseases Report Years Considered
 Figure 16. Drug-Coated Balloon for Peripheral Artery Diseases Sales Share by Manufacturers in 2024
 Figure 17. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Drug-Coated Balloon for Peripheral Artery Diseases Players: Market Share by Revenue in Drug-Coated Balloon for Peripheral Artery Diseases in 2024
 Figure 19. Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2020-2031)
 Figure 22. North America Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2020-2031)
 Figure 23. United States Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2020-2031)
 Figure 26. Europe Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Region (2020-2031)
 Figure 34. China Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Drug-Coated Balloon for Peripheral Artery Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Drug-Coated Balloon for Peripheral Artery Diseases by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Drug-Coated Balloon for Peripheral Artery Diseases by Type (2020-2031)
 Figure 55. Global Drug-Coated Balloon for Peripheral Artery Diseases Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Drug-Coated Balloon for Peripheral Artery Diseases by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Drug-Coated Balloon for Peripheral Artery Diseases by Application (2020-2031)
 Figure 58. Global Drug-Coated Balloon for Peripheral Artery Diseases Price (US$/Unit) by Application (2020-2031)
 Figure 59. Drug-Coated Balloon for Peripheral Artery Diseases Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart